COVID vaccine: SII seeks inclusion of Covovax on CoWIN as heterologous booster dose for adults Ruchika Sharma4 April 2023 11:00 AM ISTCovovax is manufactured through technology transfer from US-based vaccine maker Novavax.
Four COVID vaccine doses superior to three in patients with autoimmune rheumatic disease Dr. Shravani Dali1 April 2023 5:30 AM ISTFour COVID vaccine doses superior to three in patients with autoimmune rheumatic disease suggests a new study published in Rheumatology.The...
Johnson and Johson to discontinue late-stage study of RSV vaccine Ruchika Sharma31 March 2023 4:00 PM ISTPfizer and GSK are running a tight race to tap into the RSV vaccine market, which is estimated to be more than $5 billion and could exceed $10 billion...
Covid-19 vaccination not tied to menstrual disturbance, study finds Dr. Kamal Kant Kohli28 March 2023 8:00 PM ISTUK: A recent study has found that the COVID-19 vaccine is not associated with abnormal menstrual cycle parameters. However, women with a history of...
Indian Immunologicals wins DCGI okay to manufacture Measles-Rubella vaccine Ruchika Sharma28 March 2023 2:15 PM ISTThis vaccine has been proven through extensive human clinical trials to be immunogenic and safe for people of 9 months to 49 years, it said.
CDSCO Panel grants Sanofi's Protocol Amendment Proposal for Quadrivalent Meningococcal Conjugate Vaccine Dr. Divya Colin19 March 2023 5:45 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved Sanofi Healthcare's...
Conduct PMS study for Hepatitis B Vaccine r-DNA : CDSCO Tells Biological E Dr. Divya Colin18 March 2023 6:00 PM ISTNew Delhi: Rejecting the pharmaceutical major Biological E proposal for waiving the post marketing surveillance (PMS) study, the Subject Expert...
GSK declares positive pivotal phase III data for 5-in-1 Meningococcal ABCWY vaccine Ruchika Sharma15 March 2023 5:30 PM ISTLondon: GSK plc has announced positive headline results from the phase III trial (NCT04502693) evaluating the safety, tolerability, and immunogenicity...
Pfizer gets USFDA emergency use nod for Omicron BA.4/BA.5-adapted bivalent COVID booster in children under 5 years Ruchika Sharma15 March 2023 12:15 PM ISTThe Pfizer-BioNTech COVID-19 Vaccines (COMIRNATY) are based on BioNTech's proprietary mRNA technology and were developed by both BioNTech and Pfizer.
Too little sleep blunts immune response and may make vaccination less effective Dr. Kamal Kant Kohli14 March 2023 11:00 AM ISTResearchers have found in a new study that too little sleep blunts immune response and may make vaccination less effective.According to the...
New TB Vaccine Safe,Temperature Stable and provides prompt Immune Response Dr. Kamal Kant Kohli13 March 2023 3:15 AM ISTA clinical trial testing a freeze-dried, temperature-stable experimental tuberculosis (TB) vaccine in healthy adults found that it was safe and...
GSK, Pfizer ready to launch RSV vaccines for older adults in US Ruchika Sharma12 March 2023 2:30 PM ISTRSV is a leading cause of pneumonia in infants and the elderly, and decades of research have finally resulted in the two successful vaccines Pfizer...
